Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 19Metastatic Castration-resistant Prostate Cancer 3Prostatic Diseases 2Urogenital Neoplasms 1Renal Insufficiency 1Prostate Cancer Metastatic 1PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1Neoplasms by Site 1Neoplasms 1Metastatic Castrate Resistant Prostate Cancer (mCRPC) 1Male Urogenital Diseases 1Liver Neoplasms 1Kidney Neoplasms 1Glioma 1Glioblastoma 1Genital Neoplasms, Male 1Genital Diseases, Male 1Disease 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Hepatocellular 1Astrocytoma 1

Interventions

Specimen Handling 6Nivolumab 6Ipilimumab 6CTLA-4 Antigen 5Magnetic Resonance Spectroscopy 4cabozantinib 3Biopsy 3Blood Specimen Collection 2sodium-iodide symporter 1fludarabine 1belzutifan 1Tissue Banks 1Pluvicto 1Inulin 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Clear-cell metastatic renal cell carcinoma × Pluvicto × Clear all
NCT06783348 2026-06-04

RENALUT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting
48 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡